At just 22, Sakshi Rawat chooses a different path for her future and her village, stepping into a role that challenges ...

Biotechnology today demands not just domain knowledge but also creativity, ethics, and transdisciplinary thinking, as ...

The sixth Convocation Ceremony of Maharishi University of Information Technology (MUIT), Lucknow, widely regarded as one of ...

The Office of the Commissioner for Entrance Examinations (CEE) Kerala has published the provisional Second Round Stray Vacancy Allotment List for AYUSH medical and allied courses for the 2025–26 ...

Beijing has repeatedly shown the world that it is willing to weaponize its dominance of supply chains, and President Donald Trump had to de-escalate the latest rare-earth dispute during his recent ...

Sakshi Rawat’s win in Kui village marks a shift in how young people see their future. At 22, the BTech graduate chose to remain rooted, taking charge as the country’s youngest Gram Pradhan. Her ...

GSK has picked a novel protein biotech and a genomics biotech as its first collaborators under a $7 billion biobucks deal with Flagship Pioneering. Flagship’s Profound Therapeutics and Quotient ...

When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she had to go to the hospital four times a week to have her blood filtered by a ...

Ipsen is acquiring next-gen immuno-oncology biotech ImCheck Therapeutics for its investigational cancer combination therapy in a deal worth up to 1 billion euros (about $1.16 billion). The French ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

CNBC's Robert Frank joins 'Money Movers' with the latest investment trends in tech. Gavin Newsom’s odds of becoming president in 2028 Navy loses two aircraft from USS Nimitz aircraft carrier within 30 ...

Genmab’s $8 billion all-cash acquisition of Merus, advised by A&O Shearman, Latham & Watkins, NautaDutilh and Kromann Reumert, is one of the largest European biotech deals to date. A&O Shearman, ...